2018 EBC Sponsor

2018 EBC Sponsor
# 2018-04-20 # European Bifurcation Club # More about Industry


At Abbott, we're committed to helping people live their best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world – in nutrition, diagnostics, medical devices and branded generic pharmaceuticals – that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.


About Advanced Birfurcation Systems

Advanced Bifurcation Systems (“ABS”) is a clinical stage medical device company developing an innovative stenting platform for simple treatment of all bifurcation lesions in coronary angioplasties. ABS has developed a novel technology which overcomes the limitations of current approaches while simplifying the procedure.  The Company’s groundbreaking system consists of numerous differentiating features, including a unique modular independently movable dual-catheter system for provisional side-branch stenting as well as full bifurcation stenting with a proprietary crimping technology allowing for partial crimping of the main stent. 

Keep it simple and safe.
Limit the number of stents.
Respect the original bifurcation anatomy and try to reproduce it.
Aim for well apposed and well expanded stents with limited overlap. 

For more information, go to www.advancedbifurcation.com .


Advanced Birfurcation Systems
Charles Laverty
Chief Executive Officer